AbbVie is a new biopharmaceutical company with the expertise and financial performance of an established pharmaceutical leader. Through a targeted, patient-centric approach to research & development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases and contribute to the sustainability of health care systems around the world.

Here's a high-level overview about our business.

Chairman and CEO Richard A. Gonzalez
Leadership Team

Carlos Alban
Executive Vice President, Commercial Operations

William J. Chase
Executive Vice President, Chief Financial Officer

Henry O. Gosebruch
Executive Vice President and Chief Strategy Officer

Laura J. Schumacher
Executive Vice President, External Affairs, General Counsel and Corporate Secretary

Michael E. Severino, M.D.
Executive Vice President, Research & Development and Chief Scientific Officer

Timothy J. Richmond
Senior Vice President, Human Resources

Azita Saleki-Gerhardt, Ph.D.
Senior Vice President, Operations

Karen Hale
Vice President, Chief Ethics and Compliance Officer

Learn more »

Corporate Headquarters North Chicago, Illinois, USA
Business Specialty-focused, research-based biopharmaceutical company
Web Address
Stock Exchange Listing New York [ABBV:NYSE]
2017 Revenue

$28.22 billion

Learn more »

Leading Products

AbbVie is a global healthcare company whose passion lies in developing advanced therapies to address the world’s most difficult health problems.

Visit our US products page for prescribing information »

Research Centers

Lake County, Illinois, USA

Worcester, Massachusetts, USA

Ludwigshafen, Germany

Redwood City, California, USA

Sunnyvale, California, USA (Pharmacyclics)

Tokyo, Japan

Cambridge, Massachusetts, USA (Neuroscience)

South San Francisco, California USA (Stemcentrx)


Focus on immunology, oncology, neurology, virology

Learn more »

Countries Where Our Products Help Patients 175+
Employees Worldwide ~29,000
Primary Research and Manufacturing Facilities 22


<< Back